Clinical Trial: Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935213) titled 'Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study' on Nov. 02.

Brief Summary: Helicobacter pylori Infection in South Korea: Seroprevalence, Risk Factors, and Association with Colorectal Adenoma

Study Start Date: July 01, 2023

Study Type: OBSERVATIONAL

Condition: HELICOBACTER PYLORI INFECTIONS Colon Adenomas

Recruitment Status: COMPLETED

Sponsor: Seoul National University Bundang Hospital

Information provided by (Responsible Party): Nayoung Kim, Seoul National University Bundang Hospital

Published by HT Digital Content Services with permission from Health Daily D...